Colonial Coal International
CVE:CADColonial Coal International Corp. engages in the acquisition, exploration, and development of coal properties in Canada. It owns a 100% interest in the Huguenot coal project, a coal project with seventeen licenses covering an area of approximately 7,592 hectares. The company also holds interest in Flatbed coal property with eight coal licenses covering approximately 9,077 hectares in the Liard Mining Division, northeastern British Columbia. Colonial Coal International Corp. is headquartered in Vancouver, Canada.
Corsa Coal
CVE:CSOCorsa Coal Corp. mines, processes, and sells metallurgical coal. The company is also involved in the exploring, acquiring, and developing coal resource properties. It produces and sells metallurgical coal used for the production of coke from its mines in the Northern Appalachia coal region of the United States. The company serves steel and coke producers. It markets and sells its coal in North America, Asia, and Europe. The company is headquartered in Friedens, Pennsylvania.
Nuvo Pharmaceuticals
TSE:MRVNuvo Pharmaceuticals Inc., doing business as Miravo Healthcare, provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticaria; Cambia, a nonsteroidal anti-inflammatory drug for migraine; Suvexx/Treximet, a migraine medicine; NeoVisc, an injectable viscosupplement for osteoarthritis; and Resultz, FullMarks, and LAUSBUB for head lice infestations. The company also provides Bezalip SR for patients with high cholesterol or high levels of triglycerides; Proferrin, an iron supplement for the prevention and treatment of iron deficiency; Fiorinal 1 and Fiorinal C1 for the relief of tension-type headaches; Collatamp G for surgical implantation during surgery; PegaLAX, a laxative for the treatment of occasional constipation and irregularity; Mutaflor, a probiotic for the management and relief of chronic constipation and associated abdominal pain and cramps; MoviPrep for the cleansing of the colon in preparation for colonoscopy; and Soriatane to treat psoriasis and other keratinization disorders. In addition, it offers Pennsaid and Pennsaid 2% topical treatments for osteoarthritic pain; Vimovo for relief of arthritis symptoms; SYNERA and RAPYDAN topical patches used to help prevent pain associated with needle sticks and other superficial skin procedures; Yosprala for the prevention of heart attacks and strokes; and Heated Lidocaine/Tetracaine Patch, a topical patch applied prior to painful medical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was incorporated in 1983 and is headquartered in Mississauga, Canada.